Selected article for: "blood sample and Sample collection"
Author: Sabbatino, Francesco; Conti, Valeria; Franci, Gianluigi; Sellitto, Carmine; Manzo, Valentina; Pagliano, Pasquale; De Bellis, Emanuela; Masullo, Alfonso; Salzano, Francesco Antonio; Caputo, Alessandro; Peluso, Ilaria; Zeppa, Pio; Scognamiglio, Giosuè; Greco, Giuseppe; Zannella, Carla; Ciccarelli, Michele; Cicala, Claudia; Vecchione, Carmine; Filippelli, Amelia; Pepe, Stefano
Title: PD-L1 Dysregulation in COVID-19 Patients
  • Cord-id: 29wfx051
  • Document date: 2021_6_7
    • ID: 29wfx051
    Snippet: The COVID-19 pandemic has reached direct and indirect medical and social consequences with a subset of patients who rapidly worsen and die from severe-critical manifestations. As a result, there is still an urgent need to identify prognostic biomarkers and effective therapeutic approaches. Severe-critical manifestations of COVID-19 are caused by a dysregulated immune response. Immune checkpoint molecules such as Programmed death-1 (PD-1) and its ligand programmed death-ligand 1 (PD-L1) play an i
    Document: The COVID-19 pandemic has reached direct and indirect medical and social consequences with a subset of patients who rapidly worsen and die from severe-critical manifestations. As a result, there is still an urgent need to identify prognostic biomarkers and effective therapeutic approaches. Severe-critical manifestations of COVID-19 are caused by a dysregulated immune response. Immune checkpoint molecules such as Programmed death-1 (PD-1) and its ligand programmed death-ligand 1 (PD-L1) play an important role in regulating the host immune response and several lines of evidence underly the role of PD-1 modulation in COVID-19. Here, by analyzing blood sample collection from both hospitalized COVID-19 patients and healthy donors, as well as levels of PD-L1 RNA expression in a variety of model systems of SARS-CoV-2, including in vitro tissue cultures, ex-vivo infections of primary epithelial cells and biological samples obtained from tissue biopsies and blood sample collection of COVID-19 and healthy individuals, we demonstrate that serum levels of PD-L1 have a prognostic role in COVID-19 patients and that PD-L1 dysregulation is associated to COVID-19 pathogenesis. Specifically, PD-L1 upregulation is induced by SARS-CoV-2 in infected epithelial cells and is dysregulated in several types of immune cells of COVID-19 patients including monocytes, neutrophils, gamma delta T cells and CD4+ T cells. These results have clinical significance since highlighted the potential role of PD-1/PD-L1 axis in COVID-19, suggest a prognostic role of PD-L1 and provide a further rationale to implement novel clinical studies in COVID-19 patients with PD-1/PD-L1 inhibitors.

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and adaptive immune response innate: 1, 2, 3, 4, 5, 6, 7
    • acute ards respiratory distress syndrome and adaptive immune system: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and adaptive viral infection immune response: 1
    • acute ards respiratory distress syndrome and lmwh weight heparin: 1, 2, 3, 4, 5, 6, 7
    • acute ards respiratory distress syndrome and los hospital stay: 1, 2, 3, 4, 5, 6, 7
    • acute ards respiratory distress syndrome and los hospital stay length: 1, 2, 3, 4, 5, 6, 7
    • acute ards respiratory distress syndrome and low molecular lmwh weight heparin: 1, 2, 3, 4, 5, 6, 7
    • acute ards respiratory distress syndrome and low number: 1
    • acute ards respiratory distress syndrome and lung adenocarcinoma: 1, 2, 3
    • acute ards respiratory distress syndrome and lung biopsy: 1, 2, 3, 4, 5, 6, 7, 8
    • acute ards respiratory distress syndrome and lung epithelium: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute ards respiratory distress syndrome and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
    • acute ards respiratory distress syndrome and lung tissue biopsy: 1
    • acute chronic infection and adaptive immune response: 1
    • acute chronic infection and adaptive immune response innate: 1
    • acute chronic infection and adaptive immune system: 1, 2
    • acute chronic infection and los hospital stay: 1
    • acute chronic infection and los hospital stay length: 1
    • acute chronic infection and lung tissue: 1, 2